From the Journals
Results come from the largest multicenter cohort study in these patients.
The rate of major bleeding was similar with apixaban and dalteparin.
SAN DIEGO—In the phase 3 CASSINI trial, prophylaxis with rivaroxaban reduced the rate of venous thromboembolism (VTE) and VTE-related death in...
SAN DIEGO – The CASSINI trial evaluates VTE prophylaxis in ambulatory patients receiving systemic therapy.
CHICAGO – Ethnicity and limb infection are independent predictors of poor outcomes, including limb amputation, in TAO.